SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Feb-24 5:37 PM View: | Prime Medicine, Inc. (PRME) | 15-Feb-24 | Private Purchase | 3,200,000 | $6.25 | $20,000,000.00 | 26% 12.26M to 15.46M | |
12-Dec-23 7:52 PM View: | Neumora Therapeutics, Inc. (NMRA) | 08-Dec-23 | Acquisition (other) Duplicate | 1,879,650 | -- | -- | 6% 30.05M to 31.93M | |
20-Sep-23 6:15 AM View: | Neumora Therapeutics, Inc. (NMRA) | 19-Sep-23 | Conversion | 17,424,700 | -- | -- | 164% 10.62M to 28.05M | |
20-Sep-23 6:16 AM View: | Neumora Therapeutics, Inc. (NMRA) | 19-Sep-23 | Conversion Duplicate | 17,424,700 | -- | -- | 164% 10.62M to 28.05M | |
20-Sep-23 6:15 AM View: | Neumora Therapeutics, Inc. (NMRA) | 19-Sep-23 | Purchase | 1,500,000 | $17.00 | $25,500,000.00 | 5% 28.05M to 29.55M | |
20-Sep-23 6:16 AM View: | Neumora Therapeutics, Inc. (NMRA) | 19-Sep-23 | Purchase Duplicate | 1,500,000 | $17.00 | $25,500,000.00 | 5% 28.05M to 29.55M | |
26-Oct-22 8:01 PM View: | Prime Medicine, Inc. (PRME) | 24-Oct-22 | Conversion | 11,456,600 | -- | -- | 100% 11.46M to 22.91M | |
26-Oct-22 8:01 PM View: | Prime Medicine, Inc. (PRME) | 24-Oct-22 | Market Purchase Duplicate | 800,000 | $17.00 | $13,600,000.00 | 3% 22.91M to 23.71M | |
20-Jul-21 8:53 PM View: | Erasca, Inc. (ERAS) | 20-Jul-21 | Conversion | 11,055,600 | -- | -- | 100% 0 to 11.06M | |
23-Jun-21 4:29 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Conversion | 2,508,810 | -- | -- | 100% 0 to 2.51M | |
26-Feb-19 10:00 PM View: | Sienna Biopharmaceuticals, ... (SNNA) | 22-Feb-19 | Market Purchase Duplicate | 2,165,800 | $2.50 | $5,414,500.00 | 296% 732.49K to 2.9M | 1% |